A detailed history of Gamma Investing LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 229 shares of HUMA stock, worth $1,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares
229
Previous 158 44.94%
Holding current value
$1,108
Previous $758,000 64.38%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$5.11 - $9.46 $362 - $671
71 Added 44.94%
229 $1.25 Million
Q2 2024

Jul 02, 2024

BUY
$2.87 - $9.1 $132 - $418
46 Added 41.07%
158 $758,000
Q4 2023

Feb 01, 2024

BUY
$1.99 - $3.12 $222 - $349
112 New
112 $372,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $499M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.